Miller Anestesia

532 / 2894

412. Linton DM, Thornington RE: Etomidate as a rectal
induction agent, part II: A clinical study in children.
S Afr Med J 64:309–310, 1983.
413. Fragen RJ, Avram MJ, Henthorn TK, Caldwell NJ:
A pharmacokinetically designed etomidate infu-
sion regimen for hypnosis. Anesth Analg 62:654–
660, 1983.
414. Sear JW, Walters FJ, Wilkins DG, Willatts SM: Eto-
midate by infusion for neuroanaesthesia: Kinetic
and dynamic interactions with nitrous oxide.
Anaesthesia 39:12–18, 1984.
415. Fragen R, Shanks C, Molteni A: Effect on plasma
cortisol concentration of a single induction dose of
etomidate or thiopentone. Lancet 2:625, 1983.
416. Schuttler J, Schwilden H, Stoeckel H: Infusion stra-
tegies to investigate the pharmacokinetics and
pharmacodynamics of hypnotic drugs: Etomidate
as an example. Eur J Anaesthesiol 2:133–142,
1985.
417. Meuldermans W, Heykants J: The plasma protein
binding and distribution of etomidate in dog, rat
and human blood. Arch Int Pharmacodyn Ther
221:150, 1976.
418. Johnson KB,Egan TD,Layman J,et al: The influence
of hemorrhagic shock on etomidate: A pharmaco-
kinetic and pharmacodynamic analysis. Anesth
Analg 96:1360–1368, 2003.
419. van Beem H, Manger FW, van Boxtel C, van Bentem
N: Etomidate anaesthesia in patients with cirrhosis
of the liver: Pharmacokinetic data. Anaesthesia
38(Suppl):61–62, 1983.
420. Arden JR, Holley FO, Stanski DR: Increased sensi-
tivity to etomidate in the elderly: Initial distribution
versus altered brain response. Anesthesiology
65:19–27, 1986.
421. Evans RH, Hill RG: The GABA-mimetic action of
etomidate [proceedings]. Br J Pharmacol 61:484P,
1977.
422. Lingamaneni R, Hemmings HC Jr: Differential
interaction of anaesthetics and antiepileptic drugs
with neuronal Na+ channels, Ca2+ channels, and
GABA(A) receptors. Br J Anaesth 90:199–211,
2003.
423. Blednov YA, Jung S, Alva H, et al: Deletion of the
alpha 1 or beta2 subunit of GABAA receptors reduces
actions of alcohol and other drugs. J Pharmacol Exp
Ther 304:30–36, 2003.
424. Cold GE, Eskesen V, Eriksen H, et al: CBF and
CMRO2 during continuous etomidate infusion
supplemented with N 2 O and fentanyl in patients
with supratentorial cerebral tumour: A dose-res-
ponse study. Acta Anaesthesiol Scand 29:490–494,
1985.
425. Dearden NM, McDowall DG: Comparison of eto-
midate and althesin in the reduction of increased
intracranial pressure after head injury. Br J Anaesth
57:361–368, 1985.
426. Modica PA, Tempelhoff R: Intracranial pressure
during induction of anaesthesia and tracheal intu-
bation with etomidate-induced EEG burst suppres-
sion. Can J Anaesth 39:236–241, 1992.
427. Renou A,Vernhiet J, Macrez P: Cerebral blood flow
and metabolism during etomidate anaesthesia in
man. Br J Anaesth 50:1047, 1978.
428. Tulleken CA, van Dieren A, Jonkman J, Kalenda Z:
Clinical and experimental experience with etomi-
date as a brain protective agent. J Cereb Blood Flow
Metab 2(Suppl 1)S92–S97, 1982.
429. Takanobu S, Piyush M, Drummond J: A compari-
son of the cerebral protective effects of etomidate,
thiopental, and isoflurane in a model of forebrain
ischemia in the rat. Anesth Analg 76:990, 1993.
430. Drummond JC, Cole DJ, Patel PM, Reynolds LW:
Focal cerebral ischemia during anesthesia with eto-
midate, isoflurane, or thiopental: A comparison of
the extent of cerebral injury. Neurosurgery 37:742–
748, 1995.
431. Guo J, White J, Batjer H: Limited protective effects
of etomidate during brainstem ischemia in dogs.
J Neurosurg 82:278, 1995.
432. Ghoneim MM, Yamada T: Etomidate: A clinical
and electroencephalographic comparison with
thiopental. Anesth Analg 56:479–485, 1977.
433. Lees NW, Hendry JG: Etomidate in urological
outpatient anaesthesia: A clinical evaluation.
Anaesthesia 32:592–597, 1977.
434. Ebrahim E, DeBoer G, Luders H: Effect of etomi-
date on the electroencephalogram of patients with
epilepsy. Anesth Analg 65:1004, 1986.
435. Thornton C, Heneghan CP, Navaratnarajah M, et al:
Effect of etomidate on the auditory evoked response
in man. Br J Anaesth 57:554–561, 1985.
436. Guldager H, Sondergaard I, Jensen FM, Cold G:
Basophil histamine release in asthma patients after
in vitro provocation with Althesin and etomidate.
Acta Anaesthesiol Scand 29:352–353, 1985.
437. Morgan M, Lumley J, Whitwam JG: Respiratory
effects of etomidate. Br J Anaesth 49:233–236, 1977.
438. Colvin MP, Savege TM, Newland PE, et al: Cardio-
respiratory changes following induction of anaes-
thesia with etomidate in patients with cardiac
disease. Br J Anaesth 51:551–556, 1979.
439. Craig J, Cooper GM, Sear JW: Recovery from day-
case anaesthesia: Comparison between methohexi-
tone, Althesin and etomidate. Br J Anaesth
54:447–451, 1982.
440. Ouedraogo N, Marthan R, Roux E: The effects of
propofol and etomidate on airway contractility in
chronically hypoxic rats. Anesth Analg 96:1035–
1041, 2003.
441. Ogawa K, Tanaka S, Murray PA: Inhibitory effects
of etomidate and ketamine on endothelium-depen-
dent relaxation in canine pulmonary artery. Anes-
thesiology 94:668–677, 2001.
442. Gooding JM, Weng JT, Smith RA, et al: Cardiovas-
cular and pulmonary responses following etomi-
date induction of anesthesia in patients with
demonstrated cardiac disease. Anesth Analg 58:40–
41, 1979.
443. Gooding JM, Corssen G: Effect of etomidate on the
cardiovascular system. Anesth Analg 56:717–719,
1977.
444. Criado A, Maseda J, Navarro E, et al: Induction of
anaesthesia with etomidate: Haemodynamic study
of 36 patients. Br J Anaesth 52:803–806, 1980.
445. Lischke V, Wilke HJ, Probst S, et al: Prolongation of
the QT-interval during induction of anesthesia in
patients with coronary artery disease. Acta Anaes-
thesiol Scand 38:144–148, 1994.
446. Allolio B, Dorr H, Stuttmann R: Effect of a single
bolus dose of etomidate upon eight major corticos-
teroid hormones and plasma ACTH. Clin Endocri-
nol (Oxf) 22:281, 1985.
447. Lamberts SW, Bons EG, Bruining HA, de Jong FH:
Differential effects of the imidazole derivatives eto-
midate, ketoconazole and miconazole and of
metyrapone on the secretion of cortisol and its pre-
cursors by human adrenocortical cells. J Pharmacol
Exp Ther 240:259–264, 1987.
448. Boidin MP: Steroid response to ACTH and to
ascorbinic acid during infusion of etomidate for
general surgery. Acta Anaesthesiol Belg 36:15–22,
1985.
449. Duthie DJ, Fraser R, Nimmo WS: Effect of induc-
tion of anaesthesia with etomidate on corticosteroid
synthesis in man. Br J Anaesth 57:156–159, 1985.
450. Crozier TA, Beck D, Schlaeger M, et al: Endocrino-
logical changes following etomidate, midazolam, or
methohexital for minor surgery. Anesthesiology
66:628–635, 1987.
451. Crozier TA, Schlaeger M, Wuttke W, Kettler D:
[TIVA with etomidate-fentanyl versus midazolam-
fentanyl: The perioperative stress of coronary
surgery overcomes the inhibition of cortisol synthe-
sis caused by etomidate-fentanyl anesthesia].
Anaesthetist 43:605–613, 1994.
452. Lundy JB, Slane ML, Frizzi JD: Acute adrenal
insufficiency after a single dose of etomidate.
J Intensive Care Med 22:111–117, 2007.
453. St Pierre M, Dunkel M, Rutherford A, Hering W:
Does etomidate increase postoperative nausea? A
double-blind controlled comparison of etomidate
in lipid emulsion with propofol for balanced anaes-
thesia. Eur J Anaesthesiol 17:634–641, 2000.
454. Korttila K, Aromaa U: Venous complications after
intravenous injection of diazepam, flunitrazepam,
thiopentone and etomidate. Acta Anaesthesiol
Scand 24:227, 1980.
455. Galloway PA, Nicoll JM, Leiman BC: Pain reduc-
tion with etomidate injection. Anaesthesia 37:352–
353, 1982.
456. Doenicke AW, Roizen MF, Hoernecke R, et al:
Solvent for etomidate may cause pain and adverse
effects. Br J Anaesth 83:464–466, 1999.
457. Huter L, Schreiber T, Gugel M, Schwarzkopf K:
Low-dose intravenous midazolam reduces etomi-
date-induced myoclonus: A prospective, randomi-
zed study in patients undergoing elective
cardioversion. Anesth Analg 105:1298–1302, 2007.
458. Olkkola KT, Tammisto T: Quantitation of the inte-
raction of rocuronium bromide with etomidate,
fentanyl, midazolam, propofol, thiopentone, and
isoflurane using closed-loop feedback control of
infusion of rocuronium. Eur J Anaesthesiol Suppl
9:99–100, 1994.
459. Famewo C, Odugbesan C: Further experience with
etomidate. Can Anaesth Soc J 25:130, 1978.
460. Van de Wiele B, Rubinstein E, Peacock W, Martin
N: Propylene glycol toxicity caused by prolonged
infusion of etomidate. J Neurosurg Anesthesiol
7:259–262, 1995.
461. Shulman MS, Edelmann R: Use of etomidate for
elective cardioversion. Anesthesiology 68:656, 1988.
462. Schuttler J, Schwilden H, Stoekel H: Pharmacokine-
tics as applied to total intravenous anaesthesia:
Practical implications. Anaesthesia 38(Suppl)
53–56, 1983.
463. de Bruijn NP, Hlatky MA, Jacobs JR, et al: General
anesthesia during percutaneous transluminary
coronary angioplasty for acute myocardial infarc-
tion: Results of a randomized controlled clinical
trial. Anesth Analg 68:201–207, 1989.
464. Avramov MN, Husain MM, White PF: The compa-
rative effects of methohexital, propofol, and etomi-
date for electroconvulsive therapy. Anesth Analg
81:596–602, 1995.
465. Ledingham I, Finlay W,Watt I: Etomidate and adre-
nocortical function [letter]. Lancet:1434, 1983.
466. Maze M, Tranquilli W: Alpha-2 adrenoceptor ago-
nists: Defining the role in clinical anesthesia. Anes-
thesiology 74:581–605, 1991.
467. Kaukinen S, Kaukinen L, Eerola R: Preoperative and
postoperative use of clonidine with neurolept anaes-
thesia. Acta Anaesthesiol Scand 23:113–120, 1979.
468. Bloor BC, FlackeWE: Reduction in halothane anes-
thetic requirement by clonidine, an alpha-adrener-
gic agonist. Anesth Analg 61:741–745, 1982.
469. GerlachAT, :Anupdated
review. Ann Pharmacother 41:245–252, 2007.
470. Tobias JD: Dexmedetomidine: applications in
pediatric critical care and pediatric anesthesiology.
Pediatr Crit Care Med 8:115–131, 2007.
532 Farmacología y anestesia II